ReviewTrends in cell biology2025
Decoding human cardiovascular development and disease through single-cell transcriptomic and epigenomic profiling.
Review in Trends in cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Role of Homeobox (HOX) Genes in Adult Cardiovascular Disease: From Developmental Regulators to Therapeutic Targets.Cureus · 2025Review
- Decoding cardiac metabolic reprogramming through single-cell multi-omics: from mechanisms to therapeutic applications.Frontiers in cell and developmental biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Concomitant progress in the fields of microfluidics, microscale molecular biology, next-generation sequencing, and analytical methods for whole transcriptomic datasets has transformed our ability to understand complex cellular state changes at the single-cell level. New cell types have been discovered and cell transition states and intermediate phenotypes have been characterized across diverse developmental and disease contexts. More recently, integrating transcriptomic and epigenomic data has dramatically extended our understanding of transcriptional regulons and gene regulatory networks (GRNs) that determine gene expression and individual cellular phenotypes. Applied to cardiac biology, combined transcriptomic and epigenomic profiling has allowed the characterization of the developmental trajectories and molecular mechanisms that give rise to the diverse cell lineages of the adult heart and contribute to the pathogenesis of genetic diseases. In this review, we present the latest methodological innovations, discuss the computational strategies for multiomic data integration, and highlight how these advances are reshaping our undestanding of heart development and disease mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.